Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis

Insights

Early treatment for clinically isolated syndrome (CIS) with disease-modifying therapies (DMTs) can delay multiple sclerosis (MS) progression. Nurses are key in educating patients on early DMT benefits for better outcomes.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Clinical Therapeutics

Background:

  • Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease.
  • Clinically isolated syndrome (CIS) may precede definite MS.
  • Disease-modifying treatments (DMTs) improve MS clinical presentation and reduce neurological damage.

Purpose of the Study:

  • To evaluate the impact of early DMT initiation in patients with CIS.
  • To assess the role of nurses in patient education regarding early treatment.

Main Methods:

  • Review of existing literature on DMTs for CIS.
  • Analysis of treatment effects on delaying conversion to definite MS.
  • Assessment of MRI-based neurological damage markers.

Main Results:

  • Initiating interferon-beta or glatiramer acetate in CIS patients delays conversion to definite MS.
  • Early DMTs show improvements in neurological damage measures on MRI.
  • Patient education by nurses is crucial for treatment adherence and understanding.

Conclusions:

  • Early initiation of DMT for CIS is recommended.
  • Nurses play a vital role in patient counseling regarding early intervention benefits.
  • Prompt treatment can significantly alter the disease course and improve patient outcomes.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
68
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K